Cross‐Ethnic Variant Screening and Burden Analysis of PTPA in Parkinson's Disease
Movement Disorders · 2023
DOI: 10.1002/mds.29411 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2023. Verfasst von Chunyu Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Laboratory of Neurodegenerative Disorders, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan Un…. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Parkinson Disease, Parkinsonian Disorders. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Recently, homozygous variants in PTPA were identified as the disease cause for two pedigrees with early‐onset parkinsonism and intellectual disability. Although the initial link between PTPA and parkinsonism has been established, further replication was still necessary.
Objectives
To evaluate the genetic role of PTPA in Parkinson's disease (PD).
Methods
We analyzed rare variants of PTPA in cohorts of Asian and European ancestries (N case = 2743, N control = 8177) with whole‐exome sequencing, and further explored the functional effect of the target variant.
Results
One patient with early‐onset PD from a consanguineous family carried the homozygous variant p.Met329Val, while her parents and elder sister with heterozygous p.Met329Val were healthy. This patient developed minor cognitive decline within 1 year, with a Montreal Cognitive Assessment (MoCA) score dropping from 28 to 25. Functional exploration with overexpression studies suggested that this variant was associated with decreased protein phosphatase 2A (PTPA) protein level by affecting protein stability, but not mRNA expression.
Conclusions
These results have broadened the mutation spectrum of PTPA , and paved the way for further research into the role of PTPA in PD. © 2023 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Laboratory of Neurodegenerative Disorders, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Junyu Lin, Kuncheng Liu, Huifang Shang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Li, C., Lin, J., Jiang, Q., Yang, T., Xiao, Y., Huang, J., Hou, Y., Wei, Q., Cui, Y., Wang, S., Xiaoting, Z., Ou, R., Liu, K., Chen, X., Song, W., Zhao, B., & Shang, H. (2023). Cross‐Ethnic Variant Screening and Burden Analysis of PTPA in Parkinson's Disease. Movement Disorders. https://doi.org/10.1002/mds.29411
Vancouver
Li C, Lin J, Jiang Q, Yang T, Xiao Y, Huang J, et al. Cross‐Ethnic Variant Screening and Burden Analysis of PTPA in Parkinson's Disease. Movement Disorders. 2023. doi:10.1002/mds.29411
BibTeX
@article{Li2023,
author = {Li, Chunyu and Lin, Junyu and Jiang, Qirui and Yang, Tianmi and Xiao, Yi and Huang, Jingxuan and Hou, Yanbing and Wei, Qianqian and Cui, Yiyuan and Wang, Shichan and Xiaoting, Zheng and Ou, Ruwei and Liu, Kuncheng and Chen, Xueping and Song, Wei and Zhao, Bi and Shang, Huifang},
title = {Cross‐Ethnic Variant Screening and Burden Analysis of PTPA in Parkinson's Disease},
journal = {Movement Disorders},
year = {2023},
doi = {10.1002/mds.29411}
}
EUVIMED